Scribe Therapeutics Inc. (Scribe), a genetic medicines company unlocking the potential of CRISPR to transform human health, today announced its participation in the following conferences: Keystone ...

Although plant cell-based bioproduction has advanced considerably during the past several years, certain elements remain largely unexplored.

UTSA’s research centers, such as the South Texas Center for Emerging Infectious Diseases (STCEID), the Cybersecurity ...

Aplastic anaemia is a rare but serious blood disorder in which the bone marrow fails to produce enough blood cells—red blood cells, white blood cells, and platelets. This condition can lead to fatig ...

The CEO of one of America’s oldest scientific societies discusses the recent cuts to scientific institutions, and how ...